Clínica Hospital Dr. Ismael Vázquez Ortiz ISSSTE, Queretaro Mexico Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2005
NCT03688958
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

Clínica Hospital Dr. Ismael Vázquez Ortiz ISSSTE, Queretaro Mexico

Active Ingredients

Drugs in Phase 2 Trials (1)

iodine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1